Oncogenic shock: Explaining oncogene addiction through differential signal attenuation

被引:92
作者
Sharma, Sreenath V.
Fischbach, Michael A.
Haber, Daniel A.
Settleman, Jeffrey
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
关键词
D O I
10.1158/1078-0432.CCR-06-0096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogene addiction describes the curious acquired dependence of tumor cells on an activated oncogene for their survival and/or proliferation, a phenomenon that has important implications for the success of targeted cancer therapies. However, the mechanisms explaining oncogene addiction remain elusive. We propose that "addiction" may be an illusion generated as a consequence of differential attenuation rates of prosurvival and proapopotic signals emanating from an oncoprotein acutely following its inactivation. According to this model, which we call "oncogenic shock," prosurvival signals dissipate quickly on oncoprotein inactivation whereas proapoptotic signals linger sufficiently long to commit the cell to an apoptotic death. This mechanism may contribute to the rapid and dramatic clinical responses observed in some cancer patients treated with selective tyrosine kinase inhibitors and could yield additional drug targets that determine the balance of signaling outputs from activated oncoproteins.
引用
收藏
页码:4392S / 4395S
页数:4
相关论文
共 14 条
  • [1] Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
    Brunet, CL
    Gunby, RH
    Benson, RSP
    Hickman, JA
    Watson, AJM
    Brady, G
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (01) : 107 - 115
  • [2] Clustered CD20 induced apoptosis: Src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis
    Hofmeister, JK
    Cooney, D
    Coggeshall, KM
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (02) : 133 - 143
  • [3] Regulation of both apoptosis and cell survival by the v-Src oncoprotein
    Johnson, D
    Agochiya, M
    Samejima, K
    Earnshaw, W
    Frame, M
    Wyke, J
    [J]. CELL DEATH AND DIFFERENTIATION, 2000, 7 (08) : 685 - 696
  • [4] Oncogene addiction: Sometimes a temporary slavery
    Jonkers, J
    Berns, A
    [J]. CANCER CELL, 2004, 6 (06) : 535 - 538
  • [5] The concept of synthetic lethality in the context of anticancer therapy
    Kaelin, WG
    [J]. NATURE REVIEWS CANCER, 2005, 5 (09) : 689 - 698
  • [6] Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446
    Masuda, K
    Shima, H
    Katagiri, C
    Kikuchi, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (34) : 32448 - 32456
  • [7] Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells
    Parmar, S
    Katsoulidis, E
    Verma, A
    Li, Y
    Sassano, A
    Lal, L
    Majchrzak, B
    Ravandi, F
    Tallman, MS
    Fish, EN
    Platanias, LC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) : 25345 - 25352
  • [8] Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation
    Reinehr, R
    Schliess, F
    Häussinger, D
    [J]. FASEB JOURNAL, 2003, 17 (02) : 731 - +
  • [9] A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38α and β MAPKs
    Tanoue, T
    Yamamoto, T
    Maeda, R
    Nishida, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) : 26629 - 26639
  • [10] The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung
    Vos, MD
    Martinez, A
    Ellis, CA
    Vallecorsa, T
    Clark, GJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) : 21938 - 21943